User Support Reference Group

Page tree

Meeting Details

Date & Time: Thursday 24th July, 2025. 11am UTC

Objectives

  • Users' discussions about the SNOMED International Drug Model and National Drug Extension Model.

Attendees:


Zoom Link

Link: Join DEUSG Zoom Meeting

Meeting Recording

Link:

Passcode:

Discussion items                                                              **DRAFT**

Item

Description

Mins

Owner

Notes & Actions

1Opening2
 Alejandro Lopez Osornio

Welcome & Notification of Recording

2Substances Co-Ordination35

Workshop/Clinic to support queries from countries currently undergoing reviews in advance of promotion. 
3Implementation of Routes of Administration for medicines15

Mia van Dorp 

Update from New Zealand on implementation of Routes of Administration
4Editorial advice for PCDs PTs5

Alejandro Lopez Osornio Karen Rees 

Consultation received from members about improving the guidance on this topic

5AOB2

Antwerp 2025:

6Topic Backlog

  • Less Granular Clinical Drug
  • Elemental Substances (Matt, AUS)
  • Substances Co-ordination
    • Step 1: Substances in multiple extensions Batch promotions complete, SI review and authoring underway
    • Step 2: Substances in one extension
    • Step 3: Ongoing Substance Co-ordination (capturing at regulator level)
  • Medication Stopped v Medication Discontinued (Karen, SI)
  • Medicinal Product promotion co-ordination (Oslo group discussion as linked to substances work + ES)
  • Value range of a |Has container type| attribute (Linda, CA)
  • Top level children of 373873005 |Pharmaceutical / biologic product| hierarchy - are members using/how are members using? (AUS) 
  • Routes of Administration - Implementation Considerations (Mia, NZ)
  • Increase range of has active ingredient to include microorganisms and natural products (Guillermo)


  • Hydration Subsumption 'Option 3' proposed by DEUSG for communication/consultation with MAG and EAG
  • Group Input on Patch Strength Representation Briefing note now being implemented
  • Dose Form Intended Site v Route of Administration (BEL) Pending implementation use-cases associated with intended site
  • Drug extension MRCM attributes (CA, AUS) SI facilitating links with CA and AUS for cross-promotion, next steps: other countries to be invited to add to catalogue

  File Modified
No files shared here yet.

  • No labels